The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 4.00 (8.00%)
Open: 52.00
High: 52.00
Low: 52.00
Prev. Close: 52.00
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

7 Feb 2023 07:00

RNS Number : 0687P
Frenkel Topping Group PLC
07 February 2023
 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group") 

Trading Update for the year ended 31 December 2022

&

Notice of Results

Strong financial performance and delivery against strategy in FY2022

Positive start to FY2023, trading in line with expectations

Frenkel Topping (AIM: FEN), a specialist financial and professional services firm operating within the personal injury and clinical negligence marketplace, is pleased to provide the following trading update for the financial year ended 31 December 2022 ("FY2022") and an outlook for the current financial year ("FY2023").

The Board expects to report revenues in line with expectations of c.£24.8m (2021: £18.4m) and adjusted EBITDA of c.£6.1m* (2021: £4.6m) for FY2022. Pleasingly, EBITDA margin has been stable year on year at c25%. The Company had £5.0m of net cash at the year end and remains debt free. Assets Under Management ("AUM") has grown to £1,187m (2021: £1,174m) during the year £129m of new AUM was added within the advisory business.

This performance demonstrates the Company's resilience in a challenging financial market, as well as the progress made by the Company in diversifying revenue streams via its focused acquisition strategy and consolidation of the Personal Injury (PI) and Clinical Negligence (CN) space.

Of note is the performance of the Group's discretionary fund manager, Ascencia Investment Management ("Ascencia"), where assets on a DFM Mandate increased to £715m (2021: £676m).

Comparing Ascencia's positive performance against a backdrop of wider market contraction and material outflows further demonstrates Ascencia's success in managing multi-asset investment solutions that are positioned to capture the upside of market fluctuations, while aiming to reduce the negative impact of market turbulence on client assets.

Ascencia's strong performance in the previous financial year continued last year, with the core risk-rated strategies outperforming their respective Private Client Indices/ARC indices. It is testament to the Group's in-house strategy and approach to risk management and something the Board is justifiably proud of. The Company views the Ascencia platform as a clear growth opportunity in the coming years and a key tool to winning future business. Ascencia portfolios are currently defensively positioned given the uncertain and opaque investment outlook, with cash ready to be deployed should the opportunity arise.

The Company has of course not been entirely immune to challenging market conditions during the year. However, the modest impact on the Group's recurring revenue, has been replaced by transactional revenue delivered by the Group's businesses acquired during the last 3 years, proving out the strategy of diversifying revenue streams. By their nature the margin profile is a little different on the transaction revenue and certain essential staff costs and wage inflation has had a modest impact in the latter part of the year, as well as funding the start-up of Keystone Case Management.

The Company is also pleased to again report its outstanding client retention rates at 99%.

The Company continued to make significant progress delivering against its strategy of consolidating the pre-settlement professional services marketplace in the PI and CN space, positioning Frenkel Topping as a market leader in its sector. During the first part of the year the Company acquired Cardinal Management Limited, which is performing to plan, and it raised a further £10m in July 2022 to support the M&A strategy, completing two further acquisitions of Somek and Associates Ltd and N-Able Services Ltd in September 2022, both of which have performed to plan and in line with management's expectations.

Outlook

The new financial year has started well and the Board is confident that the acquisitions made to date will continue to contribute revenue and profitable growth to the Group. In January 2023, subsidiaries Forths Forensics and Bidwell Henderson Cost Consultants (BH) both delivered record revenues and BH surpassed its previous highest recorded number of files received by 20%. During the year the Board also expects Keystone Case Management to start contributing. Expectations for the year to FY2023 therefore remain unchanged as a result to of the solid start to the financial year.

Where appropriate the Company will endeavour to migrate AUM onto the Ascencia platform to be managed internally in order to mitigate, as far as possible, the impact of any future abnormal market movements which Ascencia has demonstrably been able to do during the year. It will also look to drive further synergies from the acquisitions made and integrate them further into a unified platform and offering by the Group. Finally, the Company is planning some investment in data analytics in order to better capture and optimise business development opportunities across the platform.

Notice of results and update on strategy

A comprehensive update and review of the year will be provided with the Company's annual results, as well as the presentation of an ambitious growth plan.

Final results for the year ended 31 December 2022 are expected to be announced on 24th April 2023. 

* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes. Adj. EBITDA defined as before share based compensation, M&A strategy and re-organisation costs.

Richard Fraser, Chief Executive Officer of Frenkel Topping Group plc, said:  

"We are pleased to report on another year of delivery despite challenging market conditions. A backdrop of market volatility served to highlight the strength of the DFM subsidiary in the Company's portfolio as well as our strategy of diversifying revenue streams. We have executed the buy and build strategy outlined ahead of our capital raise and we are in a strong position to accelerate growth through the group in the coming years and to capitalise on a significant opportunity in the personal injury and clinical negligence space. I am incredibly proud of the teams efforts and look forward to updating shareholders on progress at the time of our results in April"

 

For further information:     

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

finnCap Ltd (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/Abigail Kelly/Milesh Hindocha (Corporate Finance)

Tim Redfern / Charlotte Sutcliffe (ECM)

About Frenkel Topping Group

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

For more information visit: www.frenkeltoppinggroup.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEQLFBXLLZBBF
Date   Source Headline
29th May 20149:28 amRNSExercise of Options
14th May 201410:45 amRNSResult of AGM
14th May 20147:00 amRNSAGM Statement
24th Mar 20147:00 amRNSPreliminary Results
24th Feb 201412:16 pmRNSAppointment of Non-Executive Director
20th Feb 20147:00 amRNSNotice of Preliminary Results
20th Jan 20143:33 pmRNSTrading Statement
9th Jan 201412:49 pmRNSNew Director Incentive Scheme
6th Dec 20139:58 amRNSHolding(s) in Company
12th Nov 20133:59 pmRNSHolding(s) in Company
11th Nov 201311:31 amRNSDirector/PDMR Shareholding
26th Sep 20138:51 amRNSHolding(s) in Company
25th Sep 201312:13 pmRNSHolding(s) in Company
6th Sep 20139:26 amRNSHolding(s) in Company
5th Sep 20132:34 pmRNSDirector/PDMR Shareholding
14th Aug 20133:17 pmRNSDirector/PDMR Shareholding - Replacement
14th Aug 20139:44 amRNSDirector/PDMR Shareholding and Group EBT Purchase
6th Aug 20132:28 pmRNSExercise of options
15th Jul 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSNotice of Interim Results
29th May 201310:42 amRNSResult of AGM
29th May 20139:16 amRNSDirector/PDMR Shareholding
29th May 20137:00 amRNSAGM Statement
21st May 20134:10 pmRNSHolding(s) in Company
17th May 20137:00 amRNSHolding(s) in Company
15th May 20133:56 pmRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSPreliminary Results
3rd Apr 20132:57 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 20137:00 amRNSAcquisitions of Minority Interests in Subsidiaries
1st Feb 20134:49 pmRNSHolding(s) in Company
1st Feb 20131:54 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotice of Results
16th Jan 20137:00 amRNSTrading Update
30th Nov 20121:26 pmRNSHolding(s) in Company
23rd Oct 201211:23 amRNSDirector's Dealing and Group EBT Share Purchase
4th Oct 20127:00 amRNSFrenkel Topping implements new integrated platform
28th Sep 20127:00 amRNSTotal Voting Rights
10th Sep 201212:53 pmRNSDirector/PDMR Shareholding
29th Aug 201212:00 pmRNSExercise of Options
16th Jul 20127:00 amRNSInterim Results
2nd Jul 20122:07 pmRNSNotice of Interim Results
14th Jun 20126:25 pmRNSDirector/PDMR Shareholding
17th May 201211:55 amRNSResult of AGM
17th May 20127:00 amRNSAGM Statement
4th Apr 20121:42 pmRNSHolding(s) in Company
22nd Mar 20124:52 pmRNSHolding(s) in Company
20th Mar 201210:57 amRNSCalendar for 2011 Final Dividend
20th Mar 20127:00 amRNSFinal Results
22nd Feb 20124:44 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.